PNV 2.43% $2.41 polynovo limited

Ann: COVID Trading Themes - Q1 FY22 Update, page-120

  1. 257 Posts.
    lightbulb Created with Sketch. 368
    Hi Sojourner,
    nice article (even the bit about DCF's)
    but yes, Covid certainly has impacted the roll out of BTM but this is going to wane as an issue and quicker than people realise

    I read an interesting article from an Oxford professor of philosophical epidemiology (no, I didn't know it was a thing either)...
    what she said was that we all need to get vaccinated so that on a population basis we achieve 90% double vaccinated, we then need to give booster shots to those who are immunocompromised
    and then we basically have to catch the virus
    this because only by catching the virus will we, as individuals develop long term immunity, and we as a population develop herd immunity
    the alternative would be to keep vaccinating everyone on a 6-12 monthly basis, with the inevitable reduction in vaccination rates as time passed

    fortunately her proposal is not as drastic as it seems because the risk of becoming severely unwell after being double vaccinated is markedly reduced and also because Merck have recently developed an oral antiviral which halves the hospitalisation rate in those who do still get sick

    so what this means for PNV is that over the next 6-12 months the impact of Covid on the roll out of BTM will become less and less..

 
watchlist Created with Sketch. Add PNV (ASX) to my watchlist
(20min delay)
Last
$2.41
Change
-0.060(2.43%)
Mkt cap ! $1.649B
Open High Low Value Volume
$2.40 $2.45 $2.35 $2.103M 876.2K

Buyers (Bids)

No. Vol. Price($)
41 11488 $2.40
 

Sellers (Offers)

Price($) Vol. No.
$2.41 8225 22
View Market Depth
Last trade - 15.12pm 19/07/2024 (20 minute delay) ?
PNV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.